Issue 4/2010
Content (20 Articles)
Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
Kensei Tobinai, Michinori Ogura, Dai Maruyama, Toshiki Uchida, Naokuni Uike, Ilseung Choi, Kenichi Ishizawa, Kuniaki Itoh, Kiyoshi Ando, Masafumi Taniwaki, Naomi Shimada, Ken Kobayashi
C/EBPβ and CHOP participate in Tanshinone IIA-induced differentiation and apoptosis of acute promyelocytic leukemia cells in vitro
Kaiji Zhang, Jian Li, Wentong Meng, Hongyun Xing, Yiming Yang
Bortezomib plus dexamethasone for relapsed or treatment refractory multiple myeloma: the collaborative study at six institutes in Kyoto and Osaka
Tsutomu Kobayashi, Junya Kuroda, Kazuho Shimura, Teruaki Akaogi, Eri Kawata, Miki Kiyota, Takashi Tanaka, Yuri Kamitsuji, Satoshi Murakami, Mayumi Hatsuse, Akira Okano, Toshiki Iwai, Satomi Ueda, Masahiko Koshida, Hitoji Uchiyama, Yosuke Matsumoto, Hiroto Kaneko, Nobuhiko Uoshima, Yutaka Ueda, Yutaka Kobayashi, Chihiro Shimazaki, Shigeo Horiike, Masafumi Taniwaki
Artesunate inhibiting angiogenesis induced by human myeloma RPMI8226 cells
Hao Chen, Liang Shi, Xiaoyang Yang, Shihui Li, Xiaoling Guo, Ling Pan
Establishment of an HS23 stromal cell-dependent myeloma cell line: fibronectin and IL-6 are critical
Akira Sakai, Miyo Oda, Mitsuhiro Itagaki, Noriaki Yoshida, Koji Arihiro, Akiro Kimura
Efficacy of pretreatment of allografts with methoxypolyethylene glycol-succinimidyl-propionic acid ester in combination with an anti-OX40L monoclonal antibody in relieving graft-versus-host disease in mice
Yihong Huang, Saran Feng, Renxian Tang, Bing Du, Kailin Xu, Xiuying Pan
A nonradiation-containing, intermediate-dose methotrexate regimen for elderly patients with primary central nervous system lymphoma
Kennichi Taoka, Yasushi Okoshi, Noriaki Sakamoto, Shingo Takano, Akira Matsumura, Yuichi Hasegawa, Shigeru Chiba
Selective KIT inhibitor KI-328 and HSP90 inhibitor show different potency against the type of KIT mutations recurrently identified in acute myeloid leukemia
Akane Tsujimura, Hitoshi Kiyoi, Yukimasa Shiotsu, Yuichi Ishikawa, Yumiko Mori, Hiroshi Ishida, Tsutomu Toki, Etsuro Ito, Tomoki Naoe
Successful salvage treatment of blastic natural killer cell lymphoma with methotrexate
Shoko Kobayashi, Masanao Teramura, Miyuki Arai, Akihiro Masuda, Hideaki Mizoguchi, Toshiko Motoji
Acute renal failure associated with systemic polyoma BK virus activation in a patient with peripheral T-cell lymphoma
Kazunari Aoki, Shinichi Kotani, Tatsuo Ichinohe, Tadakazu Kondo, Takayuki Ishikawa
Histiocytic sarcoma with two immunohistopathologically distinct populations
Kanako Wakahashi, Manabu Shimoyama, Yoshio Katayama, Kentaro Minagawa, Kenji Yoshida, Ryohei Sasaki, Shunji Nakayama, Hiroshi Yokozaki, Emmy Yanagita, Tomoo Itoh, Yoshitake Hayashi, Toshimitsu Matsui
Incidental carcinomas detected by PET/CT scans in patients with malignant lymphoma
Kazuya Sato, Katsutoshi Ozaki, Shin-ichiro Fujiwara, Iekuni Oh, Tomohiro Matsuyama, Ken Ohmine, Takahiro Suzuki, Masaki Mori, Tadashi Nagai, Kazuo Muroi, Keiya Ozawa
Coexistence of chronic myeloid leukemia and pulmonary plasmacytoma mimicking primary lung cancer
Hee Jin Kim, Moon Jin Kim, Min Jeong Lee, Jong-Hwa Ahn, Ho-Su Kim, In-Suk Kim, Jong Sil Lee, Gyeong-Won Lee
Sustained improvement in cardiac function with persistent amyloid deposition in a patient with multiple myeloma-associated cardiac amyloidosis treated with bortezomib
Hiroya Tamaki, Yoshiro Naito, Masaaki Lee-Kawabata, Yuki Taniguchi, Hiroyuki Hao, Seiichi Hirota, Seiki Hasegawa, Tohru Masuyama, Hiroyasu Ogawa
Aggressive sporadic histiocytic sarcoma with immunoglobulin heavy chain gene rearrangement and t(14;18)
Eiko Hayase, Mitsutoshi Kurosawa, Masakatsu Yonezumi, Sachiko Suzuki, Hiroaki Suzuki
Expanded distribution of the T315I mutation among hematopoietic stem cells and progenitors in a chronic myeloid leukemia patient during imatinib treatment
Yosuke Minami, Tomohiro Kajiguchi, Akihiro Abe, Toshihito Ohno, Hitoshi Kiyoi, Tomoki Naoe
A case of anaplastic large cell lymphoma, ALK positive, primary presented in the skin and relapsed with systemic involvement and leukocytosis after years of follow-up period
Masataka Hosoi, Motoshi Ichikawa, Yoichi Imai, Mineo Kurokawa
Bortezomib for post-allogeneic hematopoietic stem transplantation relapse and GVHD in multiple myeloma: a single institute experience
Junya Kuroda, Tsutomu Kobayashi, Yasuhiko Tsutsumi, Mio Yamamoto, Muneo Ohshiro, Nana Sasaki, Yuji Shimura, Shinsuke Mizutani, Hisao Nagoshi, Miki Kiyota, Ryuko Nakayama, Hitoji Uchiyama, Yosuke Matsumoto, Shigeo Horiike, Chihiro Shimazaki, Masafumi Taniwaki
Postremission gemtuzumab ozogamicin for elderly patients with acute myelogenous leukemia with favorable characteristics and comorbid conditions
Motoshi Ichikawa, Akira Hangaishi, Yasuhito Nannya, Mineo Kurokawa
AA amyloidosis associated with macroglobulinemia
Raine Tatara, Tadashi Nagai, Hiroyuki Kobayashi, Kaoru Hatano, Takahiro Suzuki, Kazuo Muroi, Keiya Ozawa